what are the differences between semaglutide and tirzepatide Why is a better option than for weight loss A lot of our patients

Dan Lock explores how the experiences and motivations of individuals using glucagon-like peptide 1 drugs for weight loss may differ from those managing diabetes or heart disease

The Trump administration has also revived Most Favoured Nation pricing, requiring drugmakers to match US Medicaid prices to those paid in peer nations, as per CNN

Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional

In this article, we explore the concept of GLP1 access equity and offer practical solutions for clinicians, health systems, and policymakers to ensure fair treatment access for all, especially amid limited supply and high demand